Our People


Scott Gray-Owen 

Headshot of Scott Gray Owen

Director, Emerging and Pandemic Infections Consortium (EPIC)

Professor, Molecular Genetics

Professor Gray-Owen has been Director of U of T’s Combined Containment Level 3 lab (C-CL3) for more than a decade, providing regulatory and research oversight. His infectious disease-focused research aims to understand molecular and immunologic interactions that govern immunity and immunopathogenesis. He has consulted for biotechnology and vaccine companies, research foundations and public health agencies, and sat on national and international infection-focused panels. Prof. Gray-Owen is an inventor on 21 patents and co-founded Engineered Antigens Inc., focused on protein structure-based design of vaccine immunogens targeting human and livestock pathogens. 

Natasha Christie-Holmes 

Headshot of Natasha Christie
Director, Strategy & Partnerships, EPIC 

Dr. Christie-Holmes has managed the high-containment facilities at U of T for 13 years, developing the detailed regulatory and operational program underpinning the impactful research output of the labs. Her research expertise is in the areas of molecular virology, viral evolution and the dynamics of immune escape during viral infections. In her regulatory role, she has helped the Public Health Agency of Canada develop biosafety and biosecurity regulations. During the COVID-19 pandemic, Dr. Christie-Holmes developed a core team of CL3-trained staff to support SARS-CoV-2 research. She has led several major research projects in partnership with governmental and industry collaborators, providing key insights into decontamination of SARS-CoV-2 on PPE and persistence of the virus on currency, among other findings.

View EPIC Researchers

EPIC is a research consortium that promotes and supports interdisciplinary collaboration among researchers at U of T and at EPIC partner institutions.